Cell Factories

L., R.; H., M.
June 2008
Forbes Asia;6/16/2008, Vol. 4 Issue 11, p65
The article focuses on the use of stem still to fill the missing body parts. Emmanuel Baetge, chief scientific officer at San Diego, California-based Novocell Inc. is using embryonic stem cells to cure Type 1 diabetes. His works shows vast promise of stem cell transplants and huge hurdles of becoming a medical reality. Meanwhile, other targets for stem cells would be the ailments including spinal cord injury and Parkinson's disease which are tougher targets than diabetes.


Related Articles

  • First Working Pancreatic Beta Cells Derived from ESCs. Breindl, Anette // BioWorld Today;2/21/2008, Vol. 19 Issue 35, p1 

    The article discusses the findings of a study conducted by researchers from biotechnology firm Novocell Inc., which reported that they were able to generate insulin-sensitive pancreatic beta cells from embryonic stem cells. The research paper will be published in the March 2008 issue of "Nature...

  • Stem cell insulin.  // New Scientist;10/28/2006, Vol. 192 Issue 2575, p16 

    The article focuses on a study conducted by researcher Emmanuel Baetge and his colleagues at Novocell in San Diego, California, which developed insulin-secreting cells from human embryonic stem cells. Pancreatic cells were developed by the researchers by coaxing stem cells with chemicals....

  • SCI CHAT.  // Odyssey;Apr2005, Vol. 14 Issue 4, p47 

    Reports that embryonic stem cells do not represent a human life.

  • US deliberates on embryonic stem cells, cloning. Fox, Jeffrey L. // Nature Biotechnology;Sep2001, Vol. 19 Issue 9, p791 

    Examines deliberations concerning embryonic stem cells and human cloning in the United States. Plan for funding human embryonic stem cell research; Opposition to humane cloning; Potential applications of human cell cloning technology.

  • A cloning first. Aldhous, Peter // New Scientist;10/8/2011, Vol. 212 Issue 2833, p6 

    The article cites a report in a 2011 issue of the journal "Nature" regarding research by Dieter Egli and Scott Noggle of the New York Stem Cell Foundation Laboratory in New York City and colleagues who cloned the world's first human embryonic stem cells (hESCs).

  • Politics Trumps Science. Smith, Wesley J. // Human Life Review;Summer2001, Vol. 27 Issue 3, p36 

    Examines the conflict between science and politics on embryonic stem-cell research in the United States. Removal of a text in stem-cell research due to its political impact; Article on the defects in a cloned mice from embryonic stem cells; Efforts in Congress for a ban to human cloning.

  • President Reagan Would Have Opposed ESCR. Thomas, Cal // Human Life Review;Summer2001, Vol. 27 Issue 3, p51 

    Examines the opposition of Ronald Reagan embryonic stem cell research in the United States. Defense of human life; Banning of human cloning; Flexibility of federal regulation.

  • Embryonic Stem Cell Patents and Human Dignity. David Resnik // Health Care Analysis;Sep2007, Vol. 15 Issue 3, p211 

    Abstract  This article examines the assertion that human embryonic stem cells patents are immoral because they violate human dignity. After analyzing the concept of human dignity and its role in bioethics debates, this article argues that patents on human embryos or totipotent...

  • Brain gain. Cohen, Philip; Ainsworth, Claire // New Scientist;6/30/2001, Vol. 170 Issue 2297, p5 

    Deals with a proposed legislation banning human cloning in the United States. Stand of President George W. Bush on human cloning; Implications for research on embryonic stem cells (ESC); Advantages and disadvantages of ESC.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics